Jim Simons Igm Biosciences, Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 75,800 shares of IGMS stock, worth $110,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,800

Previous 66,500 13.98%

Holding current value

$110,668

Previous $1.1 Million 57.87%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$6.05 - $17.83 $56,265 - $165,818	9,300 Added 13.98%	75,800 $463,000
Q3 2024 Nov 13, 2024	SELL	$6.28 - $17.68 $264,972 - $745,972	-42,193 Reduced 38.82%	66,500 $1.1 Million
Q2 2024 Aug 09, 2024	BUY	$6.51 - $11.47 $394,460 - $695,001	60,593 Added 125.97%	108,693 $746,000
Q1 2024 May 13, 2024	BUY	$8.68 - $17.36 $99,820 - $199,640	11,500 Added 31.42%	48,100 $464,000
Q4 2023 Feb 13, 2024	SELL	$3.94 - $8.79 $213,942 - $477,296	-54,300 Reduced 59.74%	36,600 $304,000
Q3 2023 Nov 14, 2023	SELL	$6.66 - $10.64 $566,766 - $905,464	-85,100 Reduced 48.35%	90,900 $759,000
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $1.18 Million - $1.87 Million	133,300 Added 312.18%	176,000 $1.62 Million
Q1 2023 May 12, 2023	SELL	$13.74 - $25.76 $688,374 - $1.29 Million	-50,100 Reduced 53.99%	42,700 $587,000
Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $1.24 Million - $2.09 Million	80,200 Added 636.51%	92,800 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $351,576 - $615,828	-22,800 Reduced 64.41%	12,600 $287,000
Q2 2022 Aug 12, 2022	SELL	$13.27 - $25.5 $382,176 - $734,400	-28,800 Reduced 44.86%	35,400 $638,000
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $693,814 - $1.54 Million	51,700 Added 413.6%	64,200 $1.72 Million
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $344,875 - $829,875	12,500 New	12,500 $367,000
Q4 2020 Feb 10, 2021	SELL	$47.41 - $115.03 $990,868 - $2.4 Million	-20,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$43.0 - $84.01 $490,200 - $957,714	11,400 Added 120.0%	20,900 $1.54 Million
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $487,350 - $714,494	9,500 New	9,500 $694,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

19.5M

Call Options Held

61.3K

Put Options Held

36.7K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $42.3M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account